Yu Jeffrey 4

4 · OneMedNet Corp · Filed Apr 24, 2026

AI-generated summary of this filing

Updated Apr 24, 2026

OneMedNet (ONMD) 10% Owner Jeffrey Yu Buys Stock

What Happened

Jeffrey Yu, a reported 10% owner of OneMedNet Corp (ONMD), acquired a total of 1,123,043 shares on April 1, 2026. That consists of a $750,000 subscription purchase of 903,614 shares at $0.83/share and a grant/issuance of 219,429 shares (valued at $182,126) at the same $0.83 VWAP-based price. Net cash invested across both actions was about $932,126. These were purchases/awards (not sales).

Key Details

Transaction dates and prices:
- 2026-04-01 — Open market/private purchase (Code P): 903,614 shares @ $0.83, $750,000 (subscription agreement).
- 2026-04-01 — Grant/award (Code A): 219,429 shares @ $0.83, $182,126 (issued in lieu of prior cash compensation).
Total shares acquired: 1,123,043; total value: ~$932,126.
Filing: Form 4 filed 2026-04-24 reporting transactions on 2026-04-01 (23 days later). Form 4s are generally due within 2 business days; this timing may indicate a late filing — review the filing for any timeliness code or explanation.
Shares owned after transaction: not specified in the summary provided in this request; see the Form 4 for total beneficial ownership reported.
Notable footnotes:
- F1: $750k subscription agreement; shares priced using the 10-trading-day VWAP prior to purchase.
- F2: 219,429 shares issued in lieu of prior cash compensation, priced using the 10-trading-day VWAP.
- F3: Some shares are held in a trust with an independent trustee; Mr. Yu disclaims beneficial ownership of those trust-held shares per the filing.

Context

Purchases and awards like these represent insider buying/acquisition activity (a purchase plus compensation conversion) rather than a sale; many retail investors view insider purchases as a potentially positive signal, though they do not guarantee future company performance.
Because Mr. Yu is a reported 10% owner (not necessarily an executive role listed here), note that insider status may reflect significant ownership and different reporting rules; the filing’s footnotes and trust disclaimer may affect how much beneficial ownership he is considered to hold.

Form 4

Period: 2026-04-01

DirectorChief Medical Officer10% Owner

Transactions

Holdings

Footnotes (3)

[F1]On April 1, 2026, the issuer entered into a subscription agreement with the reporting person for a $750,000 investment in the issuer. The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the purchase date.
[F2]Represents shares issued in lieu of prior cash compensation owed to the reporting person. The shares were valued at the volume-weighted average price for the 10 trading days immediately prior to the issuance date.
[F3]The shares are held by trust with an independent trustee, in which the reporting person has no investment control. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 or for any other purpose.

Signature

/s/ Robert Golden, Attorney-in-Fact|2026-04-24

1 file